LOUISE TOBEY: Open Payments
NPI 1841252004 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 16 payments from 8 companies in 2025. Trend: 2023 $1,198 · 2024 $1,444 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 4 | $114 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Daiichi Sankyo Inc. | 2 | $59 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| TerSera Therapeutics LLC | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| Celgene Corporation | 1 | $14 |
Products named: BRUKINSA, ENHERTU, ENJAYMO, LUTATHERA, Zoladex, IMFINZI, KEYTRUDA, REBLOZYL.
Industry payments across UT — which companies pay providers there.
